tradingkey.logo

Sanara Medtech Inc

SMTI
25.040USD
+0.830+3.43%
收盘 12/22, 16:00美东报价延迟15分钟
223.63M总市值
亏损市盈率 TTM

Sanara Medtech Inc

25.040
+0.830+3.43%

关于 Sanara Medtech Inc 公司

Sanara Medtech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets. Its Sanara Surgical segment primarily markets and sells soft tissue repair and bone fusion products for use in the operating room or other sterile environments. Its Tissue Health Plus segment is focused on value-based wound care services. It markets and distributes CellerateRX Surgical Activated Collagen, FORTIFY TRG Tissue Repair Graft and FORTIFY FLOWABLE Extracellular Matrix as well as a portfolio of advanced biologic products focusing on ACTIGEN Verified Inductive Bone Matrix, ALLOCYTE Plus Advanced Viable Bone Matrix, BiFORM Bioactive Moldable Matrix, TEXAGEN Amniotic Membrane Allograft, and BIASURGE Advanced Surgical Solution to the surgical market. BIAKOS Antimicrobial Wound Gel and others are the products sold in the wound care market.

Sanara Medtech Inc简介

公司代码SMTI
公司名称Sanara Medtech Inc
上市日期Apr 07, 1994
CEOMuppalla (Suresh V)
员工数量141
证券类型Ordinary Share
年结日Apr 07
公司地址1200 Summit Avenue
城市FORT WORTH
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编76102
电话18175292300
网址https://sanaramedtech.com/
公司代码SMTI
上市日期Apr 07, 1994
CEOMuppalla (Suresh V)

Sanara Medtech Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Seth D. Yon
Mr. Seth D. Yon
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
89.85K
+46.60%
Mr. Ronald T. (Ron) Nixon
Mr. Ronald T. (Ron) Nixon
Executive Chairman of the Board
Executive Chairman of the Board
64.04K
--
Ms. Ann Beal Salamone
Ms. Ann Beal Salamone
Director
Director
22.70K
+14.12%
Ms. Sara N. Ortwein
Ms. Sara N. Ortwein
Independent Director
Independent Director
20.80K
+18.70%
Mr. Eric D. Tanzberger
Mr. Eric D. Tanzberger
Independent Director
Independent Director
17.66K
+25.52%
Mr. Eric D. Major
Mr. Eric D. Major
Independent Director
Independent Director
9.39K
+53.64%
Mr. Keith G. Myers
Mr. Keith G. Myers
Independent Director
Independent Director
4.94K
+150.13%
Mr. Suresh V. (Sam) Muppalla
Mr. Suresh V. (Sam) Muppalla
President and Chief Executive Officer of Tissue Health Plus, LLC
President and Chief Executive Officer of Tissue Health Plus, LLC
2.97K
--
Mr. Jacob A. Waldrop
Mr. Jacob A. Waldrop
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Roszell Mack, III
Mr. Roszell Mack, III
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Seth D. Yon
Mr. Seth D. Yon
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
89.85K
+46.60%
Mr. Ronald T. (Ron) Nixon
Mr. Ronald T. (Ron) Nixon
Executive Chairman of the Board
Executive Chairman of the Board
64.04K
--
Ms. Ann Beal Salamone
Ms. Ann Beal Salamone
Director
Director
22.70K
+14.12%
Ms. Sara N. Ortwein
Ms. Sara N. Ortwein
Independent Director
Independent Director
20.80K
+18.70%
Mr. Eric D. Tanzberger
Mr. Eric D. Tanzberger
Independent Director
Independent Director
17.66K
+25.52%
Mr. Eric D. Major
Mr. Eric D. Major
Independent Director
Independent Director
9.39K
+53.64%

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
业务USD
名称
营收
占比
Soft tissue repair products
22.66M
87.73%
Bone fusion products
3.14M
12.17%
SaaS
26.58K
0.10%
由于公司未披露,未能获取相关数据
业务
地区
业务USD
名称
营收
占比
Soft tissue repair products
22.66M
87.73%
Bone fusion products
3.14M
12.17%
SaaS
26.58K
0.10%

股东统计

更新时间: 12月5日 周五
更新时间: 12月5日 周五
持股股东
股东类型
持股股东
持股股东
占比
FA Sanara, L.L.C.
39.30%
Stuckert (James W)
10.82%
Tall Pines Capital LLC
5.74%
Howell (Solomon Oden Jr)
5.49%
The Vanguard Group, Inc.
2.04%
其他
36.61%
持股股东
持股股东
占比
FA Sanara, L.L.C.
39.30%
Stuckert (James W)
10.82%
Tall Pines Capital LLC
5.74%
Howell (Solomon Oden Jr)
5.49%
The Vanguard Group, Inc.
2.04%
其他
36.61%
股东类型
持股股东
占比
Corporation
45.04%
Individual Investor
20.27%
Investment Advisor
6.43%
Investment Advisor/Hedge Fund
4.42%
Research Firm
0.98%
Hedge Fund
0.78%
Bank and Trust
0.11%
Pension Fund
0.11%
其他
21.85%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
109
1.11M
12.48%
-19.18K
2025Q2
125
6.82M
76.76%
+464.64K
2025Q1
128
6.77M
77.90%
+391.75K
2024Q4
125
6.79M
77.72%
+603.56K
2024Q3
120
6.67M
76.37%
+483.73K
2024Q2
117
5.99M
68.68%
-126.89K
2024Q1
114
5.90M
70.54%
-174.47K
2023Q4
113
5.89M
70.53%
-138.63K
2023Q3
112
5.89M
70.55%
-196.98K
2023Q2
105
5.91M
70.95%
+122.70K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
FA Sanara, L.L.C.
3.51M
39.45%
--
--
Apr 11, 2025
Stuckert (James W)
966.97K
10.86%
--
--
Apr 11, 2025
Tall Pines Capital LLC
512.87K
5.76%
+512.87K
--
Sep 30, 2024
Howell (Solomon Oden Jr)
490.39K
5.51%
--
--
Apr 11, 2025
The Vanguard Group, Inc.
175.98K
1.98%
-20.48K
-10.43%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
187.10K
2.1%
-6.12K
-3.17%
Jun 30, 2025
Stonebridge Wealth Management, LLC
119.66K
1.34%
+19.60K
+19.59%
Jun 30, 2025
Yon (Seth D)
89.85K
1.01%
+28.56K
+46.60%
Sep 15, 2025
Geode Capital Management, L.L.C.
77.74K
0.87%
-11.01K
-12.41%
Jun 30, 2025
Marshall Wace LLP
71.51K
0.8%
+42.24K
+144.28%
Jun 30, 2025
查看更多

持股ETF

更新时间: 12月2日 周二
更新时间: 12月2日 周二
机构名称
占比
Texas Capital Texas Small Cap Equity Index ETF
0.05%
WisdomTree US SmallCap Fund
0.03%
iShares Micro-Cap ETF
0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.01%
ProShares UltraPro Russell2000
0%
Dimensional US Core Equity 1 ETF
0%
Invesco Russell 2000 Dynamic Multifactor ETF
0%
iShares Russell 2000 ETF
0%
Global X Russell 2000 Covered Call ETF
0%
Global X Russell 2000 ETF
0%
查看更多
Texas Capital Texas Small Cap Equity Index ETF
占比0.05%
WisdomTree US SmallCap Fund
占比0.03%
iShares Micro-Cap ETF
占比0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
占比0.01%
ProShares UltraPro Russell2000
占比0%
Dimensional US Core Equity 1 ETF
占比0%
Invesco Russell 2000 Dynamic Multifactor ETF
占比0%
iShares Russell 2000 ETF
占比0%
Global X Russell 2000 Covered Call ETF
占比0%
Global X Russell 2000 ETF
占比0%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据

常见问题

Sanara Medtech Inc的前五大股东是谁?

Sanara Medtech Inc 的前五大股东如下:
FA Sanara, L.L.C.持有股份:3.51M,占总股份比例:39.45%。
Stuckert (James W)持有股份:966.97K,占总股份比例:10.86%。
Tall Pines Capital LLC持有股份:512.87K,占总股份比例:5.76%。
Howell (Solomon Oden Jr)持有股份:490.39K,占总股份比例:5.51%。
The Vanguard Group, Inc.持有股份:175.98K,占总股份比例:1.98%。

Sanara Medtech Inc的前三大股东类型是什么?

Sanara Medtech Inc 的前三大股东类型分别是:
FA Sanara, L.L.C.
Stuckert (James W)
Tall Pines Capital LLC

有多少机构持有Sanara Medtech Inc(SMTI)的股份?

截至2025Q3,共有109家机构持有Sanara Medtech Inc的股份,合计持有的股份价值约为1.11M,占公司总股份的12.48%。与2025Q2相比,机构持股有所增加,增幅为-64.28%。

哪个业务部门对Sanara Medtech Inc的收入贡献最大?

在FY2025Q2,Soft tissue repair products业务部门对Sanara Medtech Inc的收入贡献最大,创收22.66M,占总收入的87.73%。
KeyAI